Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M251Revenue (TTM) $M3.8Net Margin (%)-728.9Altman Z-Score-19.2
Enterprise Value $M231EPS (TTM) $-0.4Operating Margin %-778.0Piotroski F-Score1
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-727.5Higher ROA y-yN
Price/Book34.910-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales44.55-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-81.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-566.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M110ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

AVEO is held by these investors:

AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Viswanathan Ravi10% Owner 2017-03-28Buy6,000,000$0.5354view
Sonsini Peter W.10% Owner 2017-03-28Buy6,000,000$0.5354view
SANDELL SCOTT D10% Owner 2017-03-28Buy6,000,000$0.5354view
Sakoda Jon10% Owner 2017-03-28Buy6,000,000$0.5354view
MOTT DAVID M10% Owner 2017-03-28Buy6,000,000$0.5354view
MAKOWER JOSHUA10% Owner 2017-03-28Buy6,000,000$0.5354view
Florence Anthony A. Jr.10% Owner 2017-03-28Buy6,000,000$0.5354view
BASKETT FOREST10% Owner 2017-03-28Buy6,000,000$0.5354view
BARRIS PETER J10% Owner 2017-03-28Buy6,000,000$0.5354view
Growth Equity Opportunities IV10% Owner 2017-03-28Buy6,000,000$0.5354view

Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Charlie Tian's Interview on The Next Level Show Jun 28 2017 
    Paulson Dives Deeper Into Valeant With Increased Holding Jun 27 2017 
    US Market Indexes Lower, Technology Stock Volatility a Factor Jun 27 2017 
    General Mills to Release 4th-Quarter, Full-Fiscal 2017 Results Jun 27 2017 
    Warren Buffett Interprets the State of the Economy on PBS Newshour Jun 27 2017 
    Office Space Provider Is a Good Stock to Follow Jun 27 2017 
    Don't Lose Your Faith in Cisco Systems Jun 27 2017 
    The Future of Value Investing Jun 27 2017 
    Quotes From 2 of the World's Greatest Value Investors Jun 27 2017 
    Extracts From the Bible of Value Investing Jun 27 2017 

    More From Other Websites
    Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals and Cara Therapeutics Jun 28 2017
    Here's Why AVEO Oncology Rose As Much As 13.8% Today Jun 27 2017
    AVEO's Kidney Cancer Candidate Gets CHMP Recommendation Jun 27 2017
    AVEO Oncology Announces $14M in Aggregate Gross Proceeds from Hercules Credit Facility and... Jun 27 2017
    Biotech Stocks Showing Signs of Resurgence Jun 26 2017
    Today's Research Reports on Stocks to Watch: Portola and AVEO Jun 26 2017
    AVEO Pharma surges 48% on recommendation for European approval of its cancer drug Jun 23 2017
    EU regulators greenlight U.S. biotech Aveo's kidney cancer drug Jun 23 2017
    AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell... Jun 23 2017
    AVEO Reaches Enrollment Target in Pivotal Tivozanib Study Jun 21 2017
    AVEO Oncology Announces Pivotal Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma Reaches... Jun 20 2017
    Why Is AVEO Pharmaceuticals (AVEO) Up 25% Since the Last Earnings Report? Jun 09 2017
    AVEO Oncology Announces Phase 1/2 TiNivo Trial of Tivozanib and Opdivo® (nivolumab) in RCC Advances... Jun 08 2017
    AVEO Oncology and Biodesix Announce Results from Two Investigator-Sponsored Phase 1 Studies of HGF... Jun 05 2017
    AVEO Oncology Announces Completion of a CHMP Oral Explanation for Tivozanib as a Treatment of... May 19 2017
    AVEO Announces Appointment of Matthew Dallas as Chief Financial Officer May 16 2017
    AVEO Issues Statement Regarding the Passing of Lead Director Henri A. Termeer May 15 2017
    AVEO Oncology Announces Receipt of USPTO Notice of Allowance Related to AV-353 May 08 2017
    AVEO Pharmaceuticals (AVEO) Q1 Loss Narrower Than Expected May 05 2017
    Today's Research Reports on Biotech Stocks to Watch: AVEO Pharmaceuticals and PharmAthene May 05 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat